Not Yet RecruitingNot Applicable

ZIPPER™ Stent-Graft Trial for Aortic Arch Dissection

127 participantsStarted 2025-09-30

Plain-language summary

This study is the feasible study on a new technique of ZIPPER aortic arch stentgraft system

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. Unruptured aneurysm ≥7 mm (anterior circulation) or ≥5 mm (posterior circulation)
✕. Prior rupture or high-risk morphology (daughter sac, aspect ratio \>1.6)
✕. Intracranial arterial stenosis ≥50% with poor collateral flow. Contrast allergy. Pregnancy or lactation. Anesthesia/surgery contraindications: Severe comorbidities precluding tolerance to anesthesia or surgery.

30-day major adverse event (MAE)-free rate

Timeframe: 30 days after intervention

12-month Clinical Treatment Success Rate

Timeframe: 12 months post-intervention

NCT IDNCT07170332

SponsorHangzhou Endonom Medtech Co., Ltd.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2027-09-30

Zhang Wayne W, Medical Doctorate